Abstract
Seminoma testis patients have high cure and survival rates. Radiotherapy to the para-aortic and para-iliac lymph nodes is a curative treatment option for patients with limited lymph node metastases. The most important risk following treatment is secondary tumor induction. This seems to be the case especially for tumors of the stomach, pancreas, kidneys and urinary bladder. The risk of tumor induction depends on the radiation dose delivered to a specific organ. Proton therapy has the unique capacity to reduce dose to these organs, when compared to conventional photon therapy. Starting in March 2022, proton therapy is offered in all three proton centers in the Netherlands. This article describes indications for treatment, technical aspects and scientific grounds for the use of proton therapy in seminoma patients.
| Translated title of the contribution | Proton therapy for seminoma testis |
|---|---|
| Original language | Dutch |
| Pages (from-to) | 143-146 |
| Number of pages | 4 |
| Journal | Tijdschrift voor Urologie |
| Volume | 13 |
| Issue number | 6-7 |
| DOIs | |
| Publication status | Published - Oct 2023 |
Keywords
- proton therapy
- radiation-induced tumors
- radiotherapy
- seminoma testis